INMEDICO A/S: Financial statements 2013
CVR: 78494913
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
INMEDICO A/S (CVR 78494913) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 13,399,856 and a net result of DKK 4,114,597 compared with DKK 5,643,518 the year before. That is an increase of 1.9% compared with the year before. Equity in the 2013 report amounted to DKK 10,114,304. The solvency ratio was 63%.
- Gross Profit
- DKK 13,399,856
- Profit/Loss
- DKK 4,114,597
- Equity
- DKK 10,114,304
- Total Assets
- DKK 16,051,474
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
INMEDICO A/S has published its annual report for 2012. Gross profit came to DKK 13,147,921, and the net result was DKK 5,643,518.
As of May 28, 2013, Niels Jensen has joined the board of directors of INMEDICO A/S.
As of May 28, 2013, Steen Vitten has left the board of directors of INMEDICO A/S.
About INMEDICO A/S
INMEDICO A/S was a Danish company of the type Aktieselskab based in Aarhus N, founded in 1985. The company has been dissolved on 8 March 2019. The company was registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named INMEDICO ApS and MICROPHARM PRODUCTION ApS. The company has 0 employees (2018). In 2017, the company reported a gross profit of DKK 12,245,584 and a net result of DKK 4,901,586 compared with DKK 7,355,346 the year before. Equity in the 2017 report amounted to DKK 12,699,264.